JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Treatment duration of developmental dysplasia of the hip: age and sonography.

We retrospectively assessed babies treated according to Pavlik's method and followed up in our outpatient clinic between the years 2001 and 2005, investigating the influence of age at onset of treatment and severity of sonographic pathologies on the rates of avascular necrosis and treatment duration of 343 pathological hips in 311 neonates. No osteonecrosis was observed at the 1-year follow-up. Early detection of developmental dysplasia of the hip and early initiation of treatment using Pavlik's method are important in preventing osteonecrosis, and have high success rates. When using Pavlik's method for treating developmental dysplasia of the hip, starting treatment at 13 weeks and later increases the duration of treatment.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app